SCNTP™ · the technology stack
The Technologies Behind SCNTP™
The short answer. SCNTP™ pairs its somatic cell nuclear transfer protocol work with Panacea Bio Chem's own engineering stack: peptide formulation architecture, preservation hardware, cryogenic processing and the control platform that runs them. Four technologies matter most to the programme — Peptourbillon™, Lyoprester®, Cryolapse™ and S3Pulse™. What each one is and does is described here; exact procedures, parameters and sequences are proprietary secrets and stay undisclosed.
Peptourbillon™ — the peptide architecture
The layered peptide formulation architecture — single- or multi-layer, never a blend. Each active keeps its own lyophilised phase: near-eutectic layering, ultrasound freezing, −80 °C stack, RF-assisted drying. Chemistries that would destroy each other in a blend arrive as neighbours, not mixtures. Dual-layer cakes: one active below, a second above — one chamber, zero contact. peptourbillon.com
The SCNTP™ programme's peptide technology — the chemistry paired with nuclear reprogramming — lives in this architecture.
Peptourbillon™ is a proprietary Panacea Bio Chem platform developed and invented by Bogdan Dicoias. Its composition is not publicly disclosed.
Lyoprester® — preservation and delivery
The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback. Cake and liquid never meet until the moment of use — no contamination, no transfer, no compromise. A conventional vial wets only the surface; the Lyoprester carries Peptourbillon loads approaching 200 mg. Lyoprester SS: screw a needle, inject, throw. lyoprester.com
Delicate biologicals — and few are more delicate than reprogramming factors and peptides — are only useful if they survive storage and arrive intact. Preservation is where affordability is won or lost, which is why the programme treats it as core engineering rather than packaging. Programme rationale
Lyoprester® is a proprietary Panacea Bio Chem technology developed and invented by Bogdan Dicoias. Its parameters are not publicly disclosed.
Cryolapse™ — cryogenic process control
Cryogenic pressure collapse — and the machine that pushes plungers and crimps. Cryopumping to −110 °C pulls cycles from ~13 hours toward ~4, surfactant-free; the same machine enables ElimiVoid, IncreSure and Cryoviscous. A 3× time compression on a real lyophilisation cycle, without a surfactant in sight. cryolapse.com
Cryolapse™ is a proprietary Panacea Bio Chem process developed and invented by Bogdan Dicoias. Its parameters are not publicly disclosed.
S3Pulse™ — the control brain
The control brain for every piece of Panacea hardware. Sixteen relay channels, three dipped product probes as the authority, Cryo-Triad event detection and a Kv-learning adaptive ramp — the platform that enables every other technology. 14,909 automated contract tests stand behind the control law. s3pulse.com
S3Pulse™ is a proprietary Panacea Bio Chem platform developed and invented by Bogdan Dicoias. Its parameters are not publicly disclosed.
The wider stack
These four sit inside a larger, integrated family — the Lyochrysalis™ drying chamber, TgShift™, LyoLevit™, DiastolVAC™, P-EARLs™ reconstitution liquids and more — built around one doctrine: delicate biologicals preserved cold, sealed inert, and delivered without a vial-and-syringe transfer. The full stack, with each technology's own page, lives at the research network's hub, panaceabiochem.co.uk.
What this means for SCNTP™ is stated plainly and no further: the programme's direction is to pair the protocol with chemistry and preservation engineered in-house, so that cost is attacked on every axis at once. The science behind the protocol is on the science page; the programme and the people behind it are on the about page.
